Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
OCTOBER 7, 2022
Food and Drug Administration (FDA) advisory committees, an analysis of the key patents covering drugs recently approved by the FDA, and an examination of high-risk cardiovascular devices approved by the FDA for use in children and adolescents. A full posting of abstracts/summaries of these articles may be found on our?
Let's personalize your content